Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial

The document reports on a randomized, double-blind, placebo-controlled, phase 1B clinical trial of sublingual minoxidil for the treatment of male and female pattern hair loss. The study found that sublingual minoxidil was safe and effective in promoting hair growth, with a significant increase in hair count observed in the treatment group compared to the placebo group. The authors suggest that sublingual minoxidil may be a promising treatment option for individuals with hair loss. Further studies are needed to determine the optimal dose of sublingual minoxidil and compare its efficacy to oral minoxidil.